Home › Lung Cancer › California › Mountain View
Lung Cancer clinical trials in Mountain View, CA
20 studies for Lung Cancer are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi away
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi away
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
Recruiting
- VA Palo Alto Health Care System, Palo Alto · 5 mi away
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mi away
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecruitingPhase 3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi away
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
RecruitingPhase 1/2
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 5 mi away
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RecruitingPhase 1/2
- Stanford University - Stanford Cancer Institute, Stanford · 5 mi away
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi away
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- VA Palo Alto Health Care System, Palo Alto · 5 mi away
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RecruitingPhase 2
- Stanford Cancer Institute, Stanford · 5 mi away
- Stanford Hospital and Clinics, Stanford · 5 mi away
- Stanford Hospital Investigational Drug Services, Stanford · 5 mi away
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Recruiting
- Stanford University, Palo Alto · 5 mi away
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
RecruitingPhase 1/2
- Stanford University, School of Medicine, Palo Alto · 5 mi away
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi away
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecruitingPhase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi away
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
RecruitingObservational study
- Stanford University School of Medicine, Stanford · 5 mi away
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- Stanford University, Stanford · 5 mi away
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
RecruitingPhase 1/2
- Stanford University, Stanford · 5 mi away
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
RecruitingHealthy volunteers welcome
- Standard University, Stanford · 5 mi away
Engagement of Veterans With Lung Cancer
Recruiting
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Stanford · 5 mi away
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA63 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Chicago, IL43 studies
- Arlington, VA42 studies
- Washington, DC41 studies
- Baltimore, MD41 studies
- Nashville, TN39 studies
- St. Louis, MO37 studies
- Columbus, OH36 studies
- Philadelphia, PA36 studies
Other studies in Mountain View
- Cancer (all types)38 studies
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Metastatic Cancer24 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Prostate Cancer15 studies
- Acute Lymphoblastic Leukemia14 studies
- Heart Failure14 studies
- Autism13 studies
- Endometrial Cancer12 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.